Health industry urges government to harness potential of telemedicine and home care


The government should also focus on creating asset-lean models powered by digital health to foster out-of-hospital care, remote monitoring and home care to reduce the burden on hospitals.

As part of the pre-budget expectations, the health industry urged the government to create and develop integrated and linked infrastructure capabilities such as telemedicine, home care and elderly care for equitable access to essential and quality health services.

In addition, industry experts have also pushed for healthcare to be given priority status so that the industry can benefit from the GST transition and providers and healthcare delivery establishments can benefit. loans at lower rates and longer terms. It is also essential that the government reduce duties and taxes on critical care and lifesaving equipment and medicines to reduce costs for providers and patients.

According to Dr Ashutosh Raghuvanshi, Managing Director and CEO of Fortis Healthcare, “Healthcare should be given priority status so that the sector can benefit from the transition to GST and that providers and service delivery establishments can benefit from loans at lower rates and longer terms It is also essential that the government reduces duties and taxes on critical care and lifesaving equipment and drugs to reduce costs for providers and patients .

“As the hospital sector is at the forefront as cases in India rise again, facilities in Tier 2-3 cities need to be equipped with diagnostic centers, ventilators, ICUS, health care facilities intensive and oxygen plants. We need greater investment in NCD programs as comorbidities lead to pandemic deaths and long COVID-related illnesses. There is an urgent need to allocate a separate budget for a nationwide campaign around preventive health, testing and screening as these are key to reducing the overall disease burden in India,” he added.

“The government must also focus on creating asset-lean models powered by digital health to drive out-of-hospital care, remote monitoring and home care to reduce the burden on hospitals. We need to strengthen the digital ecosystem to accelerate the adoption of new technologies to enable telemedicine for diagnosis and treatment. More investment is needed in advanced training and capacity building programs through study tools and affordable courses for doctors, nurses and healthcare workers in critical and intensive care, pulmonology, cardiology, in oncology, emergency care and trauma,” added Dr. Raghuvanshi.

Echoing similar views, Dr. Harsh Mahajan, President of NATHEALTH, “The pandemic has made us realize the need to provide hospitals in Tier 2 and 3 cities with adequate infrastructure such as diagnostic centers, beds oxygen plants, intensive care units and oxygen plants through increased budgetary expenditure and greater investment. This will also help create job opportunities and increase the resilience of the health system. now is the time to allocate funds and introduce targeted vocational and medical training programs that can address the shortage of qualified health personnel in the country The sector has not been able to benefit from the transition In fact, the embedded taxes in the sector have increased in the post-GST regime compared to the pre-GST scenario, therefore, streamlining the GST is essential to unlock the embedded credit. who is trapped in the healthcare value chain. »

“In the midst of the pandemic, the world has realized the potential of India’s pharmaceutical sector. There is no doubt that the sector is poised to grow and will contribute significantly to making India a $5 trillion economy,” said V Ashok, Group, Chief Financial Officer, ACG, one of major pharmaceutical manufacturers, adding that the sector is on the right track. recovering from the setback of the pandemic, increased investment across all segments will encourage organizations to build capacity. The PLI program launched by the government in 2021 has proven to be beneficial to the sector and the government should consider expanding the Production Linked Incentives (PLI) scheme to encourage new post-Covid investments that would provide support to micro , small and medium-sized enterprises (MSMEs).

“Bringing in new investments, incentivizing and supporting existing organizations with forward-looking policies, duty deductions and GST reductions will lower the overall cost of healthcare services, benefiting a large portion of the population. of the country and encourage organizations to invest more in R & D. Considering that India is the largest exporter of pharmaceuticals, the government could consider providing appropriate rates of Remission of Duties and Taxes on Export Commodities (RoDTEP) pharmaceutical products exported by the industry to encourage drug exports,” Ashok suggested.

“As we are still battling with the mutations of COVID-19, I believe that the upcoming budget could comprehensively respond to the health sector. Research and Development (R&D) in India and around the world has been steadily develop solutions to address existing problems and prepare for anticipated ones.Technological intervention has augmented the digital and home healthcare ecosystem, ensuring a reliable healthcare solution for the nation.However, the training and medical infrastructure need to be maintained The Centre’s current expenditure on health care is estimated at 1.2% of GDP (according to National Health Accounts, 2016-17) and is expected to reach 2.5% by 2025. And I believe that significant investment in healthcare can help sustain the national economy,” Ameera Shah, Managing Director of Metropolis Healthcare Limited, said.

According to Anand. K, CEO, SRL Diagnostics, “It is high time the government looked at minimum quality standards for the industry and also appointed a nodal agency to standardize laboratory testing across the country. Standardizing test codes by adopting LOINC codes and homogenizing lab report formats can help patients as well as clinicians. . Drawing inspiration from the CLIA standards in the United States for laboratory-developed tests, our regulatory bodies like the Central Drugs Standard Control Organization (CDSCO) can open up the regulatory framework that will help laboratories create indigenous tests suitable for the Indian population. , to encourage more research and Encourage innovation. This will reduce our reliance on imported kits for laboratory testing. India could become self-sufficient in test kits in a few years with the right kind of support from policymakers and government.

Anand further informed, “Government may also consider collaborating on public-private partnerships. SRL has executed major projects in Jharkhand, Himachal Pradesh and Uttar Pradesh and these partnerships have greatly benefited the citizens of these States Private healthcare providers with considerable infrastructure and experience in delivering high quality services can really help deliver quality diagnostics and wellness to the masses Policy makers can customize health care delivery in districts, cities and towns by leveraging big data generated by labs PPPs for such collaborations could be helpful as labs can provide actionable health insights that can improve health indicators health of a particular condition.

“The government should consider instituting a formal council that can help establish the credibility and credentials of medical laboratory professionals and allied health professionals. In the absence of any legal regulatory mechanism to oversee educational and professional standards, educational institutions have mushroomed unabated across the country,” Anand concluded.

Financial Express is now on Telegram. Click here to join our channel and stay up to date with the latest Biz news and updates.


Comments are closed.